Business

iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

LEXINGTON, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects

articleIspecimen Inc.July 25, 20233/company/ispecimen-inc/news/ispecimen-to-report-second-quarter-2023-results-on-august-2-2023
iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

About this update from Ispecimen Inc.

[{"type":"text","content":"LEXINGTON, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the second quarter ended June 30, 2023 before the market opens on Wednesday, August 2, 2023. The Company will host a conference call ad audio webcast that morning at 8:30 a.m. Eastern Time featuring remarks by Tracy Curley, CEO. Event: iSpecimen Second Quarter 2023 Results Conference CallDate:Wednesday, August 2, 2023Time:8:30 a.m. Eastern TimeDial in: 1-844-826-3035 (U.S. Toll Free) or 1-412-317-5195 (International)Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1621940&tp_key=e0a2fff245 For interested individuals unable to join the conference call, a replay will be available through August 16, 2023, at +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 10180082. An archived version of the webcast will also be available on iSpecimen’s Investor Relations site: https://investors.ispecimen.com/presentations/. About iSpecimeniSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit www.ispecimen.com. Forward Looking Statements This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “will,” “expect,” “intend,” “anticipate,” believe,” “estimate” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or fin...

More updates from Ispecimen Inc.